Published March 29, 1973 | Version v1
Report Restricted

Application of the theory of track effects to cancer therapy. Progress report

Description

A brief overall view of the status of these researches to date is given in Appendix I. A number of the results therein described were obtained during the tenure of the present grant. Included in this category are predictions of the response of the Fricke dosimeter to the neutron spectrum of the Hammersmith cyclotron source, fitting survival data on T-7 phage, assignment of parameters to diploid yeast, E. coli, and HeLa cells, development of a model of a heavy ion beam, and the design of a ridge filter for isoeffect (survival of kidney cells) in a tumor region. Some recent work on the systematics of the 1-hit detector is described in Appendix II, along with some useful applications of these systematics to the dosimetry of cancer therapy. Work is projected on the further development of an isoeffect filter, and on the provision of information from which a therapist may make a proper evaluation of the potential of heavy ion beams in therapy. Additionally effort is being expended on the reevaluation and refinement of cellular survival parameters

Availability note (English)

MF available from INIS under the Report Number.

Files

Restricted

The record is publicly accessible, but files are restricted to users with access.

Additional details

Publishing Information

Imprint Pagination
44 p.
Report number
PB--244164

INIS

Country of Publication
United States
Country of Input or Organization
United States
INIS RN
8283655
Subject category
S63: RADIATION, THERMAL, AND OTHER ENVIRONMENTAL POLLUTANT EFFECTS ON LIVING ORGANISMS AND BIOLOGICAL MATERIALS;
Resource subtype / Literary indicator
Progress Report
Descriptors DEI
ANIMAL CELLS; DOSIMETRY; FAST NEUTRONS; HEAVY IONS; NEOPLASMS; PARTICLE TRACKS; RADIATION DOSES; RADIOTHERAPY; SURVIVAL CURVES
Descriptors DEC
BARYONS; CHARGED PARTICLES; DISEASES; ELEMENTARY PARTICLES; FERMIONS; HADRONS; IONS; MEDICINE; NEUTRONS; NUCLEONS; THERAPY

Optional Information

Notes
Available from NTIS. $3.75.
Secondary number(s)
NSF/RANN/IR/GI--3156/PR/73/1.